Search research articles
Contact Us
Filters
Showing results (171-180 of 193) with videos related to
Page
of 20
Sort By:
EFSA Journal. European Food Safety Authority
|
October 29, 2024
Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-NL-2015-126) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87705 × MON 87708 × MON 89788
, Josep Casacuberta, Francisco Barro, et al.
Frontiers in Immunology
|
July 11, 2022
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease
Vincent van Unen, Laura F Ouboter, Na Li, et al.
EFSA Journal. European Food Safety Authority
|
January 21, 2026
Assessment of genetically modified soybean MON 87769 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21253)
, Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority
|
January 14, 2026
Assessment of genetically modified soybean MON 87705 for renewal authorisation under Regulation (EC) No 1829/2003 (application GMFF-2023-21236)
, Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority
|
July 31, 2020
Guidance on allergenicity assessment of genetically modified plants
, Hanspeter Naegeli, Andrew Nicholas Birch, et al.
EFSA Journal. European Food Safety Authority
|
November 18, 2024
Assessment of soy leghemoglobin produced from genetically modified <i>Komagataella phaffii</i>, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-162)
, Josep Casacuberta, Francisco Barro, et al.
Iscience
|
July 11, 2022
Imaging mass cytometry reveals the prominent role of myeloid cells at the maternal-fetal interface
Juliette Krop, Anita van der Zwan, Marieke E Ijsselsteijn, et al.
EFSA Journal. European Food Safety Authority
|
August 6, 2025
New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment
, Josep Casacuberta, Francisco Barro, et al.
Clinical & Translational Immunology
|
May 18, 2026
Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab
Daan A R Castelijn, Jolanda M W van de Water, Laura R de Baaij, et al.
EFSA Journal. European Food Safety Authority
|
July 7, 2020
Advancing human health risk assessment
Anna Lanzoni, Anna F Castoldi, George En Kass, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 193) with videos related to
Sort By:
Page
of 20
EFSA Journal. European Food Safety Authority
|
October 29, 2024
Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-NL-2015-126) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87705 × MON 87708 × MON 89788
, Josep Casacuberta, Francisco Barro, et al.
Frontiers in Immunology
|
July 11, 2022
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease
Vincent van Unen, Laura F Ouboter, Na Li, et al.
EFSA Journal. European Food Safety Authority
|
January 21, 2026
Assessment of genetically modified soybean MON 87769 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21253)
, Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority
|
January 14, 2026
Assessment of genetically modified soybean MON 87705 for renewal authorisation under Regulation (EC) No 1829/2003 (application GMFF-2023-21236)
, Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority
|
July 31, 2020
Guidance on allergenicity assessment of genetically modified plants
, Hanspeter Naegeli, Andrew Nicholas Birch, et al.
EFSA Journal. European Food Safety Authority
|
November 18, 2024
Assessment of soy leghemoglobin produced from genetically modified <i>Komagataella phaffii</i>, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-162)
, Josep Casacuberta, Francisco Barro, et al.
Iscience
|
July 11, 2022
Imaging mass cytometry reveals the prominent role of myeloid cells at the maternal-fetal interface
Juliette Krop, Anita van der Zwan, Marieke E Ijsselsteijn, et al.
EFSA Journal. European Food Safety Authority
|
August 6, 2025
New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment
, Josep Casacuberta, Francisco Barro, et al.
Clinical & Translational Immunology
|
May 18, 2026
Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab
Daan A R Castelijn, Jolanda M W van de Water, Laura R de Baaij, et al.
EFSA Journal. European Food Safety Authority
|
July 7, 2020
Advancing human health risk assessment
Anna Lanzoni, Anna F Castoldi, George En Kass, et al.
Page
of 20